SpaceX IPO launches today. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBraemar Shipping Regulatory News (BMS)

Share Price Information for Braemar Shipping (BMS)

Share Price is delayed by 15 minutes
Get Live Data
235.00    0.00 (0.00%)
Bid:
235.00
Ask:
238.00
Spread: 3.00 (1.277%)
Market Cap: £75.17m
BMS Live PriceLast checked at - London Stock Exchange

Intraday Braemar Shipping Share Chart

Director/PDMR Shareholding

10 Dec 2024 16:13

RNS Number : 5648P
Braemar PLC
10 December 2024
 

 

10 December 2024

BRAEMAR PLC

("Braemar" the "Company")

PDMR Share Dealing

 

Braemar Plc (LSE: BMS), a leading provider of expert investment, chartering and risk management advice to the shipping and energy markets, announces that on 9 December 2024, James Gundy, Group Chief Executive Officer, exercised 199,494 nil cost options ("Options") granted under the Company's Long Term Incentive Plan ("LTIP") as set out below:

 

LTIP award grant date

 

Vesting date

Two-year holding period end date

 

Number of Options exercised

 

29 October 2018

26 May 2021

26 May 2023

33,294

 

1 July 2019

26 August 2022

26 August 2024

166,200

 

 

The 2018 and 2019 LTIP awards vested following the assessment of the applicable performance conditions which were disclosed in the 2021 remuneration report (page 58) and 2022 remuneration report (page 74), both reports are available on the Company's website at Financial Reports - Braemar.

 

The exercise of the Options under the LTIP, has been satisfied through the allocation of existing ordinary shares held by the Braemar Employee Share Ownership Plan; as such, no new ordinary shares have been issued. In order to cover tax and national insurance liabilities arising from the exercise of the Options, James Gundy sold 94,112 shares on 9 December 2024 and retained the balance of 105,382 shares.

 

Following the above transactions, James Gundy's total shareholding is now 988,907 (being 3% of the Company's issued share capital). A separate TR-1 notification will be released in line with provisions in Chapter 5 of the Disclosure Guidance and Transparency Rules.

 

The notification set out below is provided in accordance with the requirements of the EU Market Abuse Regulation, which is part of UK law by virtue of the European Union (Withdrawal) Act 2018.

 

 

For further information, contact:

 

Braemar Plc

 

James Gundy, Group Chief Executive Officer

Tel +44 (0) 20 3142 4100

Grant Foley, Group Chief Financial Officer

Rebecca-Joy Wekwete, Company Secretary

Canaccord Genuity

Adam James / Harry Rees

Tel +44 (0) 20 7523 8000

Burson Buchanan

Charles Ryland / Stephanie Whitmore / Jack Devoy / Abby Gilchrist

Tel +44 (0) 20 7466 5000

 

 

 

 

Details of the person discharging managerial responsibilities / person closely associated

Name

James Gundy

 

Reason for the notification

Position/status

 

Group Chief Executive Officer

 

Initial notification /Amendment

Initial

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor 

 

Name

Braemar Plc

 

LEI

213800EV6IKTTHJ83C19

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted 

 

Description of the financial instrument, type of instrument

 

Ordinary shares of 10 pence each

Identification code

 

GB0000600931

Nature of the transaction 

 

Exercise of Options granted under the Company's LTIP in 2018

Price(s) and volume(s)

Price: £0.00

 

Volume: 33,294

 

Aggregated information

 - Price

 

- Aggregated volume

 

 

Price: £0.00

 

Volume: 33,294

Date of the transaction

9 December 2024

 

Place of the transaction 

Exercise of Options occurred outside a trading venue

 

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted 

 

Description of the financial instrument, type of instrument

 

Ordinary shares of 10 pence each

Identification code

 

GB0000600931

Nature of the transaction 

 

Exercise of Options granted under the Company's LTIP in 2019

Price(s) and volume(s)

Price: £0.00

 

Volume: 166,200

 

Aggregated information

 - Price

 

- Aggregated volume

 

 

Price: £0.00

 

Volume: 166,200

Date of the transaction

9 December 2024

 

Place of the transaction 

Exercise of Options occurred outside a trading venue

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted 

 

Description of the financial instrument, type of instrument

 

Ordinary shares of 10 pence each

Identification code

 

GB0000600931

Nature of the transaction 

 

Sale of shares to cover tax and national insurance following exercise of Options granted under the Company's LTIP in 2018 and 2019

 

Price(s) and volume(s)

Price: £2.537266

 

Volume: 94,112

 

Aggregated information

 - Price

 

- Aggregated volume

 

 

Price: £238,787.18

 

Volume: 94,112

Date of the transaction

9 December 2024

 

Place of the transaction 

London Stock Exchange (XLON)

 

 

 

Notes to Editors:

 

About Braemar Plc

Braemar provides expert investment, chartering, and risk management advice to the shipping and energy markets that enable its clients to secure sustainable returns and mitigate risk in the volatile world of shipping and energy. Our experienced brokers work in tandem with specialist professionals to form teams tailored to our customers' needs, and provide an integrated service supported by a collaborative culture.

 

Braemar joined the Official List of the London Stock Exchange in November 1997 and trades under the symbol BMS.

 

For more information, including our investor presentation, visit www.Braemar.com and follow Braemar on LinkedIn.

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHMZMMZVGGGDZM
Date   Source Headline
3rd Jun 20263:30 pmRNSNotice of AGM
2nd Jun 20265:03 pmRNSTotal Voting Rights
27th May 20267:00 amRNSBoard Changes
21st May 20267:00 amRNSFinal Results
13th May 20267:00 amRNSNotice of Results
1st May 202610:13 amRNSTotal Voting Rights
20th Apr 20264:32 pmRNSDirector/PDMR Shareholding
10th Apr 20263:26 pmRNSHolding(s) in Company
1st Apr 202610:32 amRNSTotal Voting Rights
25th Mar 20267:00 amRNSFY26 Trading Update
2nd Mar 20264:33 pmRNSTotal Voting Rights
17th Feb 20267:00 amRNSCEO Succession
2nd Feb 20265:13 pmRNSTotal Voting Rights
5th Jan 20267:00 amRNSIssue of Shares
2nd Jan 20261:49 pmRNSTotal Voting Rights
15th Dec 20257:00 amRNSIssue of Shares
2nd Dec 202511:27 amRNSTotal Voting Rights
5th Nov 20257:00 amRNSInterim Results
31st Oct 20257:00 amRNSTotal Voting Rights
27th Oct 20257:00 amRNSNotice of HY26 Results
1st Oct 202512:26 pmRNSTotal Voting Rights
25th Sep 20257:00 amRNSHY26 Trading Update
2nd Sep 202511:28 amRNSTransaction in Own Shares
1st Sep 202512:20 pmRNSTotal Voting Rights
1st Sep 20257:00 amRNSTransaction in Own Shares
29th Aug 20257:00 amRNSTransaction in Own Shares
28th Aug 20257:00 amRNSTransaction in Own Shares
27th Aug 20257:00 amRNSTransaction in Own Shares
26th Aug 20257:00 amRNSTransaction in Own Shares
22nd Aug 20259:46 amRNSTransaction in Own Shares
21st Aug 20257:00 amRNSTransaction in Own Shares
20th Aug 20257:00 amRNSTransaction in Own Shares
19th Aug 20257:00 amRNSTransaction in Own Shares
15th Aug 20257:00 amRNSTransaction in Own Shares
11th Aug 20257:00 amRNSTransaction in Own Shares
8th Aug 20257:00 amRNSTransaction in Own Shares
7th Aug 20257:00 amRNSTransaction in Own Shares
6th Aug 20257:00 amRNSTransaction in Own Shares
1st Aug 20257:00 amRNSTotal Voting Rights
1st Aug 20257:00 amRNSTransaction in Own Shares
24th Jul 20257:00 amRNSTransaction in Own Shares
23rd Jul 20257:00 amRNSTransaction in Own Shares
22nd Jul 20257:00 amRNSTransaction in Own Shares
17th Jul 20257:00 amRNSTransaction in Own Shares
16th Jul 20257:00 amRNSTransaction in Own Shares
15th Jul 20257:00 amRNSTransaction in Own Shares
14th Jul 20257:00 amRNS-ROpening of First African Office in Cape Town
14th Jul 20257:00 amRNSTransaction in Own Shares
11th Jul 20257:00 amRNSTransaction in Own Shares
10th Jul 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.